ConvaTec Group Plc Share Price and Company Fundamentals



Price
£205.6
Change
4.800 (2.390%)
52 week
165.3 - 256.0

Last traded: Last Friday at 4:11 PM

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

Key Metrics

PE ratio

-

PB ratio

-

Dividend yield

0.03%

Beta

0.63

Market cap

-

Enterprise value

-

Company profile

Industry / SectorMedical Instruments & Supplies / Healthcare
Full time employees10142
Websitehttps://www.convatecgroup.com
Mailing address3 Forbury Place 23 Forbury Road Reading RG1 3JH United Kingdom
Phone / Fax44 11 8952 8100 /

Dividends

Dividend yield

0.03%

Dividend amount

£0.06

Payout ratio

96.57%

ConvaTec Group Plc paid £0.06 dividend and the ex-dividend date was 31 Mar 2022.The dividend payout ratio is 96.57%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CTEC dividend payout ratio is more than 90% making it difficult for the company to maintain the dividends and increase it year by year.

CTEC's forward dividend amount is £0.04 and the forward dividend yield is 1.92%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on ConvaTec Group Plc.

NameTitleAgeTotal Pay
Mr. Karim BitarCEO & Director563.48M
Mr. Frank M. SchulkesExec. Officer591.08M
Mr. Jonathan P. MasonGroup CFO & Director57
Mr. Donal BalfeExec. VP and Chief of Quality & Operations
Dr. Divakar Ramakrishnan Ph.D.Exec. VP & Chief Technology Officer
Mr. Mark ReynoldsDirector of Investor Relations
Ms. Kate PostansVP of Investor Relations & Corp. Communications
Ms. Natalia KozminaExec. VP & Chief HR Officer
Mr. Christian HoengaardSr. VP & GM - USA
Ms. Kjersti Grimsrud Biotechnology, M.Sc.Pres & COO of Infusion Care60

Profitability and management effectiveness

Profit margin

5.77%

Operating margin

11.35%

Return on assets

3.89%

Return on equity

6.99%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of ConvaTec Group Plc is and its enterprise value is .

The CTEC's stocks Beta value is 0.63 making it 37% less volatile compared to LSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

ConvaTec Group Plc (LSE:CTEC) Frequently Asked Questions

1. What is ConvaTec Group Plc's Stock Symbol?

ConvaTec Group Plc trades on LSE under the ticker symbol "CTEC".

2. What is ConvaTec Group Plc's stock price today?

One share of CTEC stock can currently be purchased for approximately £205.6.

3. How can I contact ConvaTec Group Plc?

ConvaTec Group Plc's mailing address is 3 Forbury Place 23 Forbury Road Reading RG1 3JH United Kingdom. The company can be reached via phone at 44 11 8952 8100.

4. What is ConvaTec Group Plc's official website?

The official website of ConvaTec Group Plc is https://www.convatecgroup.com.